QuidelOrtho Corp (QDEL)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$27.50

Buy

$30.35

arrow-up$0.63 (+2.22%)

Prices updated at 20 Dec 2025, 00:15 EST
| Prices minimum 15 mins delay
|
Prices in USD

Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It includes applications in infectious diseases, women's health, gastrointestinal diseases, and others.

Income statement

20232024
2,998m2,783m
1,497m1,287m
257m46m
8.571.65
-10m-2,052m
607m-1,490m
Sales, General and administrative763m767m
Interest expenses179m188m
Provision for income taxes-19m-79m
Operating expenses1,240m1,241m
Income before taxes-29m-2,131m
Net income available to common shareholders-10m-2,052m
-0.15-30.54
Net interest income-177m-189m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-0.15-30.54
Free cash flow per share2.196-1.4442
Book value/share74.463347.3811
Debt equity ratio0.4889430.773496

Balance sheet

20232024
Current assets1,311m1,219m
Current liabilities834m999m
Total capital7,281m5,126m
Total debt2,614m2,681m
Total equity5,006m2,985m
Total non current liabilities--
Loans2,275m2,141m
Total assets8,563m6,424m
Total liabilities--
Cash and cash equivalents119m98m
Common stock67m67m

Cash flow

20232024
Cash at beginning of period294m120m
Cash dividends paid--
71m-112m
Investments (gains) losses-188m-150m
120m99m
Net income--
280m83m
-209m-195m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.